BlueLine — For Blue Cross and Blue Shield of Florida and Health Options Contracting Providers; BlueCross BlueShield of Florida Health Options®
November 2001
Important Updates

Medical Coverage Guidelines

Neuropsychological Testing
Neuropsychological testing may be covered when performed for the evaluation of individuals with cognitive dysfunction due to injury, disease or abnormal development of the brain. The assessments are typically performed by licensed clinical neuropsychologists, but also may be performed by neurologists, psychiatrists and psychologists. The neuropsychological examination has three general aims:

  • Identification of neuropsychological dysfunction leading to conclusions regarding the presence, type and etiology of brain dysfunction by measuring attention, executive functions, sensation and perception, motor performance, memory, language and intelligence
  • Comprehensive assessment of cognitive, perceptual, and motor strengths and weaknesses as a guide for treatment
  • Assessment of the level of performance over a broad range, for both initial evaluation and measurement of change over time.

Examples of indications for neuropsychological testing include:

  • Detection of neurologic disease based on quantitative assessment of neurocognitive abilities in conditions such as:
    • Head injuries (open or closed)
    • Anoxic injuries
    • Neurodegenerative disorders
    • Brain tumor
    • Cerebrovascular disease
    • CNS infections (e.g., HIV)
    • Demyelinating disease
    • Seizure disorder
    • Congenital or developmental disorders (e.g., cerebral palsy)
    • Extrapyramidal disease (e.g., Parkinson’s disease)
    • Chronic alcohol or drug abuse
    • Metabolic encephalopathy
    • Exposure to agents associated with cerebral dysfunction
  • Differentiation between psychogenic and neurogenic syndromes such as depression vs. dementia
  • Delineation of the neurocognitive effects of central nervous system disorders
  • Assessment of neurocognitive functions to formulate rehabilitation and/or management strategies for individuals with neurologic disorders.

Neuropsychological testing is not covered for the following:

  • Repeat testing
  • Individuals with ongoing substance abuse problems, those intoxicated at the time of the testing or those who are less than 10 days post-detox
  • Self-administered or self-scored inventories, or screening tests of cognitive function (e.g., AIMS, Folstein Mini-Mental Status Exam or similar tests). These types of tests are considered incidental to the E/M service and are not separately payable.
  • Dementia
  • Detection of cognitive deficits associated with or as a sequela to infectious disease
  • Neurological sequelae of infectious diseases
  • Diagnosis of infectious diseases involving the central nervous system.

The following codes may be used to describe neuropsychological testing:

96117 Neuropsychological testing battery (i.e., Halstead-Reitan, Luria, WAIS-R) with interpretation and report, per hour

ICD-9 diagnosis codes that support medical necessity for neuropsychological testing include the following (for all lines of business except Medicare & More):

290.0-294 Mental disorders (excludes codes for schizophrenic disorders and affective psychoses)

For Medicare & More members, coverage is consistent with local and national Medicare policy.

Reimbursement for neuropsychological testing battery (96117) is limited to eight hours during a 12-month period. Services in excess of this limitation are subject to medical review of documentation that supports medical necessity (i.e., office or progress notes, test results indicating specific tests performed, scoring, interpretation, length of time involved in testing).

HFCC/HFCWO Devices
High-frequency chest compression or high-frequency chest wall oscillation (HFCC/HFCWO) devices have been investigated as an alternative (not an adjunct) to conventional chest physical therapy (i.e., chest percussion and postural drainage) in the treatment of cystic fibrosis and other similar conditions. Three such devices include the ThAIRapy Bronchial Drainage System (ThAIRapy Vest), the Flutter device, and the intrapulmonary percussive ventilator (Percussionaire).

HFCC/HFCWO devices are considered investigational due to a lack of sufficient data to permit conclusions regarding an effect on health outcome and a lack of medical consensus regarding effectiveness.

The following codes may be used to describe HFCC/HFCWO devices.

S8200

Chest compression vest (investigational)

S8205

Chest compression system generator and hoses (for use with chest compression vest, S8200) (investigational)

For Medicare & More members, coverage is consistent with local and national Medicare policy.


Labs depend on physicians for accurate information; use lab requisition forms when referring patients

Recent data show that labs are among the top providers in submitting claims with incorrect or incomplete information. Lab claims most often are denied because of incorrect contract/member numbers, missing or invalid diagnosis codes, and incorrect patient birth dates.

Since labs do not always have direct contact with their patients, they rely on physicians to provide the correct information. It is important that physicians use the lab requisition form when they refer patients or send specimens for lab testing.

Physicians can reduce the number of pended or denied lab claims by simply completing the necessary patient information on the requisition form. Forms may vary among labs, but usually the following information is requested:

  • The referring physician’s BCBSF provider number
  • Patient name
  • Contract/member number (include alpha prefix)
  • Patient date of birth
  • Location of service
  • Date of service
  • Diagnosis code
  • CPT code


Billing

Physician payments go to weekly cycle

In November 2001, Blue Cross and Blue Shield of Florida plans to change its physician payment schedule for its insurance business. Claims will continue to process daily, but only one check and remittance advice will be mailed weekly per payee. Reducing the number of checks you receive should provide improved efficiencies and administrative expenses as you handle and/or post fewer checks for the weekly cycle.

The new payment schedule follows the cycle already in use for Health Options. You will continue to receive separate remittance advices for your patients covered by PPO, Traditional and Care Manager plans; the Federal Employee Program (FEP); the State Employees’ PPO Plan and Administrative Services Accounts (ASO). Your mailing address zip code determines which day of the week your BCBSF remittance advice will be released. The check paid date will be one day after the release day indicated below:

Day

All zip codes beginning with

Monday

30xxx, 31xxx, 34xxx

Tuesday

320xx, 321xx, 322xx, 323xx, 324xx,
325xx, 326xx

Wednesday

327xx, 328xx, 329xx

Thursday

330xx, 331xx, 332xx,333xx, 334xx

Friday

335xx, 336xx, 337xx,338xx, 339xx

Saturday

Any zip code not listed above

For questions about the new weekly payment schedule, call 800-477-3736, ext. 51289, or 904-905-1289. Please leave your name, telephone number, provider number and question; a representative will return your call.


Front-End Edits (FEE) requirements revised

A memo was sent during the week of Oct. 29 to all electronic senders, PMS vendors and in-house programmers advising of Front-End Edit enhancements. Please review this memo, as it provides valuable information regarding changes to the FEE requirements.

The memo also highlights the importance of retrieving your Claim Return Reports (CRRs). If you are an electronic sender and have not been picking up your CRRs, you may have claims that are not going to be processed because they did not make it to our adjudication systems. As a result, claims represented on the CRRs are not on our files, and a customer service representative will be unable to locate any information regarding it.

If you did not receive a copy of this memo, please contact the Claims Data Acquisition Department at
800-778-6795, Option 2, or email us at claims.dataacquisition@bcbsfl.com, and we will provide you with an additional copy via email or fax.


Products & Services

BCBSF BlueNews Q&A

Our BlueNews Seminars held throughout the state over the last several months generated numerous questions about the Front-End Edit system, Virtual Office and other claims and billing issues. To further the educational process, we begin with this issue of BlueLine a new column devoted to answering your questions.

Q. When batches of claims are submitted electronically and errors are found, is the entire batch rejected or only the specific claims with errors?

A. It depends on which format is submitted and where the editing occurs. We have editing criteria in our EDI Gateway (which is considered our ‘electronic front door’) and additional editing within our front-end edits program that occurs later in the process.

EDI Gateway
For the most part, the editing that occurs at the EDI Gateway has to do with the basic structure of the format — required records are found in the right sequences, fields contain the right type of information (alphabetic or numeric), etc. There are some specific differences based on the type of format submitted, and those differences are mentioned below.

For 1450 NSF institutional claims, we have some claim-level edits at our EDI Gateway. We will accept all claims that pass the edit criteria based on our specifications and return all claims that fail the edit criteria. For example, if 100 claims are submitted, 90 are accepted and 10 are rejected due to edit failure, the 10 claims are returned and must be corrected and resubmitted.

For all other BCBSF or HMO claims, including common format professional, common format institutional and NSF professional claims, the editing that occurs at the EDI Gateway is ‘File Level.’ This means that if there are any errors on the file, the entire file is returned and no claims are accepted. For example, if 100 claims are submitted and there is one error in the file, the entire file (all 100 claims) are returned for correction. Most of the edits at this level deal with the structure of the file, required records, sequencing and balancing. The error(s) must be corrected and the entire file resubmitted.

Front-End Edits Program
Once the claims pass our EDI Gateway, they are routed to our Front-End Edits (FEE) program. At this level, we are looking for claim-specific information and edit on a claim-by-claim basis. For example, if 100 claims are forwarded from the Gateway, 55 claims fail and 45 claims pass, the 45 claims will be forwarded to the appropriate processing systems; the other 55 claims will not pass. We will create a Claims Return Report (CRR) and place it into the submitter’s electronic mailbox. These 55 claims must be corrected and resubmitted.

Q. What if I am unable to get a copy of the Claims Return Report from my vendor or billing service?

A. You must work with your vendor or billing service to obtain these reports. It is critical that you are aware of the failed claims because these claims are not in our system and will not be considered for payment. If your vendor or billing service does not provide this capability, please contact Claims Data Acquisition for other available options at 800-778-6795, Option 2, or email us at: claims.dataacquisition@bcbsfl.com.

Q. Does VO have a target date for checking claim status on out-of-state members?

A. It is possible to check claim status on most out-of-state members today if the out-of-state claim was sent to BCBSF for processing. Enter the member number just as you do today for BCBSF products.

Q. How should we submit a claim for the handling of repeat procedures on the same day for professional component services?

A. Use modifier 26 (professional component) and modifier 76 (repeat procedure, same physician) with the appropriate procedure code. Here’s an example: If a physician performs the professional component (reads, interprets and writes a report) for procedure 71030, chest X-ray, for a patient, and the same procedure is repeated two or more times for the same patient on the same day, here’s how to submit the claim:

  • 71030 – 26 on the first line
  • 71030 – 76 on the second line
  • 71030 – 76 on the third line.


Online hospital and facility
guide now available

The Guide for Hospitals and Facilities, a comprehensive Blue Cross and Blue Shield of Florida (BCBSF) and Health Options reference guide, is now available on our website, www.bcbsfl.com.

In addition to the Guide for Hospitals and Facilities, a UB-92 Billing Instructions manual is available under the Manuals & Billing Guides section. These instructions also may be accessed directly through a link in the online Guide for Hospitals and Facilities.

The guide contains helpful information on BCBSF/Health Options products, participation agreements, utilization management programs, and claims filing and reimbursement guidelines. The online version of the guide will be updated throughout the year, so make sure to access the site often.

Paper copies of the guide will be mailed to all participating Health Options, PPC and PHS/Traditional acute care hospitals, ambulatory surgical centers, dialysis centers, and psychiatric and substance abuse facilities in November.

If you have questions regarding information contained in the guide, contact your local Network Management office.


Call routing system offers new options

Earlier this year, Blue Cross and Blue Shield of Florida implemented a new call routing system that offers a variety of service options not previously available.

Our automated customer service line at 800-727-2227 gives providers a way to obtain answers to questions about patients’ eligibility, deductible and claims status using a touch-tone telephone. You also have the option of speaking to one of our customer service associates.

The automated system is available 7 a.m. to 6:30 p.m. EST, Monday – Friday; 7 a.m. to 4 p.m. EST, Saturday.

Call 800-727-2227 or the number on the patient’s ID card, using a touch-tone telephone.

VO providers
Press 2 if you have a Virtual Office service number and are a Virtual Office provider

  • Select:
    • 1 for claims status
    • 2 to speak to a service associate regarding eligibility, benefits and medical clearance
    • 3 if you know your party’s 5-digit extension
    • 4 to speak to a service associate for any other reason
    • 5 for technical problems
    • 7 to repeat this menu

Other providers (non-VO)
Press 3 – other providers

  • Select:
    • 1 for claims status
    • 2 for eligibility, benefits and to verify the primary care physician (PCP)
    • 3 to speak to a service associate
    • 7 to repeat this menu

You may speed up the automated line by entering your response at any time without being asked for information by a prompt or a menu. You do not have to wait for all menu options to be listed before entering your response.


Pharmacy News

A call for judicious Cipro prescribing

Support Centers for Disease Control (CDC)
This is a request to ask for your support of the U.S. government and CDC requests for judicious prescribing of Cipro or doxycycline to ensure the availability of these drugs for those in need. Your effort in this regard will discourage inappropriate use that could seriously deplete national supplies of the drugs.

Prevent hoarding
By refusing to unnecessarily prescribe Cipro or doxycycline for persons to keep on hand, you will assist in preventing the development of resistance of anthrax and other bacteria. In addition, you will assist in preventing potential medical complications to these antibiotics, which include superinfections, cartilage damage, hemorrhaging, nephrotoxicity and colitis.

Blue Cross and Blue Shield of Florida’s data indicate some patients appear to be trying to stockpile personal supplies of Cipro and doxycycline in reaction to anthrax media reports. Prescribing data will continue to be monitored closely.

Patient education
If you are asked by a Blue Cross and Blue Shield of Florida or Health Options member to prescribe Cipro or doxycycline, please take the time to explain why it is not appropriate to comply with their request:

  • The President and U.S. health officials have requested that antibiotics NOT be prescribed for the purpose to have on hand for potential anthrax exposure.
  • Unnecessary prescribing of antibiotics reduces the supply of medication for those who actually are exposed and require treatment.
  • Unnecessary use of antibiotics is and has been a public health concern even prior to this anthrax scare.
  • Unnecessary use is causing bacteria to be resistant to antibiotics.
  • Antibiotics are medications; they can cause serious side effects.
  • Unnecessary use of antibiotics may cause future anthrax cases to fail to respond to antibiotic treatment.
  • Cipro is not approved for children younger than 18 years of age, and doxycycline is not approved for children younger than 8 years of age (unless used to treat for documented anthrax exposure).

Any Blue Cross and Blue Shield of Florida or Health Options member covered under our pharmacy plan who is exposed to anthrax and prescribed Cipro or doxycycline will certainly have the drug covered as a first-line defense. Following medical evaluation, further antibiotic therapy also would be covered as medically necessary.

Though Cipro and doxycycline have been getting most of the attention in connection with the anthrax outbreak, there are several other antibiotics that can be used, including penicillin, amoxicillin and ampicillin.

BCBSF requests that participating physicians follow the guidelines provided by the Centers for Disease Control and Prevention found at www.bt.cdc.gov.